332 related articles for article (PubMed ID: 29166820)
21. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
[TBL] [Abstract][Full Text] [Related]
22. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
Allison DB; Bishop JA; Ali SZ
Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
[TBL] [Abstract][Full Text] [Related]
23. ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor.
Xiao GQ; Li F; Unger PD; Katerji H; Yang Q; McMahon L; Burstein DE
Mod Pathol; 2016 Jun; 29(6):591-8. PubMed ID: 26916077
[TBL] [Abstract][Full Text] [Related]
24. Malignant Gonadal Germ Cell Tumors (Other Than Pure Germinoma) in Patients With Disorders of Sex Development: A Report of 21 Cases Based Largely on the Collection of Dr Robert E. Scully, Illustrating a High Frequency of Yolk Sac Tumor With Prominent Hepatoid and Glandular Features.
Segura SE; Young RH; Oliva E; Ulbright TM
Am J Surg Pathol; 2022 May; 46(5):664-676. PubMed ID: 34560684
[TBL] [Abstract][Full Text] [Related]
25. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
26. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience.
Bell D; Hanna EY; Agaimy A; Weissferdt A
Virchows Arch; 2015 Dec; 467(6):649-656. PubMed ID: 26407663
[TBL] [Abstract][Full Text] [Related]
27. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
Osman H; Cheng L; Ulbright TM; Idrees MT
Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
[TBL] [Abstract][Full Text] [Related]
28. The yolk sac tumor: reflections on a remarkable neoplasm and two of the many intrigued by it-Gunnar Teilum and Aleksander Talerman-and the bond it formed between them.
Young RH
Int J Surg Pathol; 2014 Dec; 22(8):677-87. PubMed ID: 25395492
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
30. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
[TBL] [Abstract][Full Text] [Related]
31. [SMARCB1 (INI1)-deficient sinonasal carcinoma: a clinicopathological analysis of six cases].
Tang SJ; Zhai CW; Yuan CC; Zhang JH; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):47-51. PubMed ID: 31914534
[No Abstract] [Full Text] [Related]
32. Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies.
Ulbright TM
Pathology; 2018 Jan; 50(1):88-99. PubMed ID: 29129333
[TBL] [Abstract][Full Text] [Related]
33. Ovarian Yolk Sac Tumor With High-Grade Serous Carcinoma in a 62-Year-Old Woman.
McCarthy WA; Masand RP
Int J Surg Pathol; 2016 Jun; 24(4):360-5. PubMed ID: 26782153
[TBL] [Abstract][Full Text] [Related]
34. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
35. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.
Agaimy A; Koch M; Lell M; Semrau S; Dudek W; Wachter DL; Knöll A; Iro H; Haller F; Hartmann A
Am J Surg Pathol; 2014 Sep; 38(9):1274-81. PubMed ID: 24832165
[TBL] [Abstract][Full Text] [Related]
36. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
37. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract][Full Text] [Related]
38. Ovarian mixed germ cell tumor with yolk sac and teratomatous components in a dog.
Robinson NA; Manivel JC; Olson EJ
J Vet Diagn Invest; 2013 May; 25(3):447-52. PubMed ID: 23604259
[TBL] [Abstract][Full Text] [Related]
39. Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels.
Li CY; Han YM; Xu K; Wu SY; Lin XY; Cao HY
Onco Targets Ther; 2021; 14():2227-2233. PubMed ID: 33824593
[TBL] [Abstract][Full Text] [Related]
40. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]